ATE354097T1 - Verfahren zur diagnose von leberfibrose. - Google Patents
Verfahren zur diagnose von leberfibrose.Info
- Publication number
- ATE354097T1 ATE354097T1 AT04025621T AT04025621T ATE354097T1 AT E354097 T1 ATE354097 T1 AT E354097T1 AT 04025621 T AT04025621 T AT 04025621T AT 04025621 T AT04025621 T AT 04025621T AT E354097 T1 ATE354097 T1 AT E354097T1
- Authority
- AT
- Austria
- Prior art keywords
- liver fibrosis
- severity
- optionally
- measuring
- diagnosis
- Prior art date
Links
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 1
- 208000019423 liver disease Diseases 0.000 abstract 2
- 102100027378 Prothrombin Human genes 0.000 abstract 1
- 108010094028 Prothrombin Proteins 0.000 abstract 1
- 102000005876 Tissue Inhibitor of Metalloproteinases Human genes 0.000 abstract 1
- 108010005246 Tissue Inhibitor of Metalloproteinases Proteins 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 229940039716 prothrombin Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04019134 | 2004-08-12 | ||
| EP04025621A EP1626280B1 (de) | 2004-08-12 | 2004-10-28 | Verfahren zur Diagnose von Leberfibrose. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354097T1 true ATE354097T1 (de) | 2007-03-15 |
Family
ID=34981126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04025621T ATE354097T1 (de) | 2004-08-12 | 2004-10-28 | Verfahren zur diagnose von leberfibrose. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070178443A1 (de) |
| EP (1) | EP1626280B1 (de) |
| JP (1) | JP4516124B2 (de) |
| CN (1) | CN101023356A (de) |
| AT (1) | ATE354097T1 (de) |
| CA (1) | CA2575475C (de) |
| DE (1) | DE602004004775T2 (de) |
| ES (1) | ES2282780T3 (de) |
| WO (1) | WO2006015874A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100999720B1 (ko) | 2008-11-13 | 2010-12-08 | 아주대학교산학협력단 | 간 경변 진단을 위한 분석방법 |
| CN102265160B (zh) * | 2008-12-24 | 2014-07-23 | 学校法人庆应义塾 | 肝病标记物、其测定方法、装置和医药品的检验方法 |
| KR101018960B1 (ko) | 2009-02-23 | 2011-03-02 | 아주대학교산학협력단 | 유의성있는 간섬유화 진단을 위한 분석 방법 |
| WO2010097472A1 (en) * | 2009-02-26 | 2010-09-02 | Universite D'angers | Improved diagnosis of liver fibrosis or cirrhosis |
| EP2409154B1 (de) * | 2009-03-19 | 2017-08-02 | Universite D'angers | Nichtinvasives verfahren zur beurteilung des fortschreitens von leberfibrose |
| CN105866423A (zh) * | 2009-05-14 | 2016-08-17 | 牛津大学之校长及学者 | 使用一组新型低丰度人类血浆蛋白生物标记对肝纤维化进行临床诊断 |
| EP2327988A1 (de) | 2009-11-28 | 2011-06-01 | Assistance Publique Hôpitaux De Paris | Verfahren zur Diagnose von fibrotischen Erkrankungen |
| EP2590665B1 (de) * | 2010-07-08 | 2015-09-16 | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | Adenovirus-ad36-e4orf1-protein zur prävention und behandlung von nicht-alkoholischer fettleber |
| CN102302358B (zh) * | 2011-06-29 | 2014-04-09 | 内蒙古福瑞医疗科技股份有限公司 | 肝纤维化检测系统 |
| EP2727520B1 (de) * | 2011-06-29 | 2019-08-21 | Inner Mongolia Furui Medical Science Co., Ltd | Vorrichtung und system zum nachweis von leberfibrose |
| CN102636642B (zh) * | 2012-04-06 | 2014-04-30 | 中国人民解放军第三0二医院 | 一种肝纤维化诊断的快速定量试纸条的制备方法 |
| ES2523903B1 (es) * | 2013-04-30 | 2015-09-09 | Fundación Pública Andaluza Progreso Y Salud | Método de obtención de datos útiles para el diagnóstico diferencial de la fibrosis hepática |
| RU2016107170A (ru) * | 2013-08-02 | 2017-09-07 | Экоусенс | Неинвазивная система для вычисления достоверной, стандартизованной и полной оценки человека или животного |
| MX356444B (es) * | 2013-09-24 | 2018-05-21 | Univ Mexico Nac Autonoma | Arreglo múltiple de anticuerpos específicos para el pronóstico, detección y vigilancia del proceso fibrogénico. |
| MX367294B (es) * | 2013-09-24 | 2019-08-05 | Univ Mexico Nac Autonoma | Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica. |
| JP7007361B2 (ja) * | 2016-08-01 | 2022-01-24 | センター ホスピタリア ユニバーシタイア ダンガース | 複数標的線維症検査 |
| US20210022715A1 (en) * | 2018-03-26 | 2021-01-28 | The General Hospital Corporation | Method for objective, noninvasive staging of diffuse liver disease from ultrasound shear-wave elastography |
| CN110070942A (zh) * | 2019-04-22 | 2019-07-30 | 深圳市绘云生物科技有限公司 | 一种基于梯度提升树模型的慢性肝病风险评估系统 |
| CN114550942B (zh) * | 2022-02-16 | 2023-06-30 | 四川大学华西医院 | 一种肝脏显著纤维化预测模型及构建方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL77144A (en) * | 1984-11-27 | 1991-04-15 | Orgenics Ltd | Method and apparatus for performing solid phase immuno-assay on test card in a plurality of samples |
| GB8803000D0 (en) * | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| ES2112916T3 (es) * | 1991-10-15 | 1998-04-16 | Multilyte Ltd | Ensayo de union que utiliza un reactivo marcado. |
| DE69832628T2 (de) * | 1997-04-23 | 2006-09-07 | Instrumentation Laboratory S.P.A. | Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz |
| DE19731465A1 (de) * | 1997-07-22 | 1999-01-28 | Boehringer Mannheim Gmbh | Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren |
| ES2288962T3 (es) * | 2000-04-28 | 2008-02-01 | Bayer Aktiengesellschaft | Diagnostico de fibrosis hepatica con algoritmos de marcadores sericos. |
| EP1150123B1 (de) * | 2000-04-28 | 2006-07-12 | Bayer Aktiengesellschaft | Diagnose von Leberfibrose mit Hilfe von Serummarkeralgorithmen |
| ES2259291T3 (es) * | 2000-08-21 | 2006-10-01 | Assistance Publique, Hopitaux De Paris | Metodo de diagnostico de enfermedad fibrotica que utiliza marcadores bioquimicos. |
| US6631330B1 (en) * | 2000-08-21 | 2003-10-07 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers |
| US6986995B2 (en) * | 2002-02-28 | 2006-01-17 | Prometheus Laboratories, Inc. | Methods of diagnosing liver fibrosis |
-
2004
- 2004-10-28 ES ES04025621T patent/ES2282780T3/es not_active Expired - Lifetime
- 2004-10-28 EP EP04025621A patent/EP1626280B1/de not_active Expired - Lifetime
- 2004-10-28 AT AT04025621T patent/ATE354097T1/de active
- 2004-10-28 DE DE602004004775T patent/DE602004004775T2/de not_active Expired - Lifetime
-
2005
- 2005-08-12 CA CA2575475A patent/CA2575475C/en not_active Expired - Fee Related
- 2005-08-12 WO PCT/EP2005/008778 patent/WO2006015874A2/en not_active Ceased
- 2005-08-12 JP JP2007525265A patent/JP4516124B2/ja not_active Expired - Fee Related
- 2005-08-12 CN CNA2005800273192A patent/CN101023356A/zh active Pending
-
2007
- 2007-02-09 US US11/673,072 patent/US20070178443A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006015874A8 (en) | 2006-04-06 |
| WO2006015874B1 (en) | 2006-11-23 |
| US20070178443A1 (en) | 2007-08-02 |
| CA2575475A1 (en) | 2006-02-16 |
| JP4516124B2 (ja) | 2010-08-04 |
| JP2008509411A (ja) | 2008-03-27 |
| EP1626280B1 (de) | 2007-02-14 |
| WO2006015874A2 (en) | 2006-02-16 |
| WO2006015874A3 (en) | 2006-09-28 |
| CA2575475C (en) | 2010-03-30 |
| DE602004004775D1 (de) | 2007-03-29 |
| CN101023356A (zh) | 2007-08-22 |
| DE602004004775T2 (de) | 2007-11-22 |
| ES2282780T3 (es) | 2007-10-16 |
| EP1626280A1 (de) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004004775D1 (de) | Verfahren zur Diagnose von Leberfibrose. | |
| DE60325617D1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
| DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| Kumar et al. | An investigation into the effect of a resin infiltrant on the micromechanical properties of hypomineralised enamel | |
| DE60239470D1 (de) | Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna | |
| DE60207979D1 (de) | Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten | |
| ATE546734T1 (de) | Risikomarker für eine herzkreislaufkrankheit | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| WO2003075745A3 (en) | Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry | |
| DE602004030586D1 (de) | Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis | |
| DK2848938T3 (da) | Evaluering af effektiviteten af en behandling hos et individ baseret på st2- niveauer | |
| ATE283487T1 (de) | Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration | |
| CA2575405A1 (en) | Method for diagnosing liver fibrosis | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| NZ599054A (en) | Diagnosis of collagen IX destruction | |
| ATE478335T1 (de) | Verfahren in echtzeit zur erkennung von akuten entzündungszuständen | |
| ATE392622T1 (de) | Verfahren zur diagnose von leberfibrose | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| ATE546547T1 (de) | Diagnose der chronischen abstossung | |
| DE602007008370D1 (de) | Verfahren zur Detektion der in-vivo-Aktivität von Neurotrypsin, Verwendung des Verfahrens und Verwendung des C-terminal 22-kDa-Fragments als Biomarker bei der Diagnose und Überwachung von Störungen im Zusammenhang mit Neurotrypsin | |
| EP1376133A4 (de) | Screening-verfahren für den prädiabetiszustand und screening-reagenz | |
| ATE554790T1 (de) | Verfahren und zusammensetzungen zur diagnose von asthma | |
| DE602005023973D1 (de) | Verfahren zur diagnose von chronischem stress und verwandten erkrankungen | |
| ATE442456T1 (de) | Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs | |
| ATE503847T1 (de) | Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1626280 Country of ref document: EP |